Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Today Montana.
Press releases published on October 28, 2025
Zymeworks Announces Participation in Upcoming Investor Conferences
VANCOUVER, British Columbia, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to- …
Swarm Oncology announces research collaboration with a leading hospital to advance T cell therapies for advanced solid cancers
London, United Kingdom October 28, 2025, Swarm Oncology Ltd. (“Swarm Oncology” or “Swarm”), a biotechnology company pioneering novel T cell therapies to achieve long-term remission in patients with advanced solid cancers, is pleased to announce a research …
Press release: Sanofi successfully prices USD 3 billion of bond issue
Sanofi successfully prices USD 3 billion of bond issue Paris, France – October 28, 2025 - Sanofi announces that it has successfully priced its offering of $3 billion of notes across 5 tranches: $400 million fixed rate notes, due November 2027, bearing …
Communiqué de presse : Sanofi place 3 milliards de dollars d’emprunts obligataires
Sanofi place 3 milliards de dollars d’emprunts obligataires Paris, 28 Octobre 2025 - Sanofi annonce avoir placé avec succès une émission obligataire en 5 tranches (les « obligations ») pour un montant de 3 milliards de dollars : 400 millions de dollars …
Kyowa Kirin and Orchard Therapeutics Announce OTL-200 Granted Orphan Regenerative Medicine Product Designation for Early-onset MLD in Japan
TOKYO, LONDON and BOSTON, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Kyowa Kirin Co., Ltd., (TSE: 4151, President and COO: Abdul Mullick, "Kyowa Kirin") and Orchard Therapeutics announced that Japan's Ministry of Health, Labor and Welfare (MHLW) has granted Orphan …
Qualigen Therapeutics to Rebrand as AIxCrypto After Stockholder Meeting on November 12, with Three Core Goals for 2025
Dubai, UAE / Beijing, China, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Qualigen Therapeutics Inc. (NASDAQ: QLGN) (“Qualigen”, “QLGN” or the “Company”), a publicly-traded technology company majority owned by Faraday Future Intelligent Electric Inc. (NASDAQ: FFAI) …
عرض أول نموذج لغوي ضخم متعدد المجالات الحيوية يفك شفرة لغة علم الأحياء البشري في المعرض العالمي للصحة في الرياض
دبي، الإمارات العربية المتحدة،, Oct. 28, 2025 (GLOBE NEWSWIRE) -- أصبحنا ولأول مرة نستطيع فهم البيانات الأعقد في جسم الإنسان وهي الحديث الدقيق بين الجينات والبروتينات والمستقلبات كلغة موحدة وليس إشارات معزولة. فقد أعلنت اليوم شركة. BioAro Inc إنجازها …
Präsentation des weltweit ersten Multi-Omics-LLM für ein umfassendes Verständnis der menschlichen Biologie auf der Global Health Exhibition in Riad
DUBAI, Vereinigte Arabische Emirate, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Zum ersten Mal können die komplexesten Daten des menschlichen Körpers – die komplizierten Wechselwirkungen zwischen unseren Genen, Proteinen und Metaboliten – nicht als isolierte …
Présentation du tout premier grand modèle de langage multiomique au monde au salon Global Health Exhibition de Riyad, ou la promesse d’un décodage du langage de la biologie humaine
DUBAÏ, Émirats arabes unis, 28 oct. 2025 (GLOBE NEWSWIRE) -- Pour la première fois, les données les plus complexes du corps humain, à savoir les interactions complexes entre nos gènes, nos protéines et nos métabolites, peuvent s’entendre non pas comme des …
UPDATE - Medidata Extends Collaboration with Sanofi for the Development of New Therapies with an Improved Patient Journey
NEW YORK, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, today announced an extension of their collaboration with Sanofi in clinical research. As part of …